Prohibition Partners
Home / Cannabis Markets / Luxembourg
Luxembourg flag

Is cannabis legal in Luxembourg?

Medical cannabis is legal in Luxembourg and adult-use is legal. Below: a free market overview, with the full sizing, regulation and trade data available from PP.

Medical: LegalAdult-use: Legal

Market size

Medical cannabis sales and registered patients in Luxembourg, 2025 actuals and the 2027 forecast. Forecasts to 2030 are in the Luxembourg data pack.

Medical sales, EUR

€4.3m2025€4.5m2026€4.7m2027202820292030
Metric202520262027202820292030
Medical sales€4.3m€4.5m€4.7m
Patients1,3701,4251,474

Forecasts to 2030 — sales, patients and the full Luxembourg series — are in the Luxembourg data pack, or scoped to your question in a bespoke brief.

See the data pack Request a brief

Source: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025)

Recently in Luxembourg

From International Cannabis Weekly, our free global briefing.

Latest issue №467
  1. Luxembourg sees launch of its first at-home cannabis growing service for consumers

    luxtimes.lu · 443 · 27 Mar 2026 · Adult-use

  2. Luxembourg continues to struggle with entrenched cannabis black market despite legal reforms

    415 · 29 Aug 2025 · Regulation

  3. Survey shows half of Luxembourg adults have tried cannabis, reflecting widespread use

    392 · 21 Mar 2025 · Health & Science

  4. Tilray Medical wins tender to supply Luxembourg with medical cannabis in 2025

    382 · 10 Jan 2025 · Medical

  5. Luxembourg's new medical cannabis guidelines spark patient concerns

    380 · 20 Dec 2024 · Medical

  6. High-THC cannabis flower no longer available on prescription in Luxembourg from next year

    Cannabis Health · 376 · 22 Nov 2024 · Medical

Medical cannabis — overview

Luxembourg introduced its medical cannabis law on 20 July 2018, with the programme officially commencing in February 2019. Under the country’s medical cannabis programme, only doctors licensed in Luxembourg and those who have specific training for its prescription may prescribe medical cannabis to patients.

Medical cannabis is dispensed at hospital pharmacies and is covered by public health insurance. Medical cannabis may be prescribed to patients who suffer from:

Serious chronic diseases – classified as long-term diseases under Article 19b(1) of the Social Security Code, which are in an advanced or terminal stage and result in severe and disabling chronic pain. Patient must also have exhausted all available drug treatments, or where such treatments are not available.

Nausea & Vomiting – due to cancer treatment through chemotherapy

Symptomatic muscle spasticity – associated to Multiple Sclerosis

As of 1 January 2025, high-THC flowers have been removed as prescribable medical cannabis, thereby limiting the roughly 1100 medical cannabis patients to balanced and high CBD flower products and cannabis oil extracts (High THC, Balanced, High CBD). The removal of high THC flowers is part of longer-term plans to phase out flower-based products altogether.

On 6 January 2025, it was announced that Tilray Deutschland GmbH was awarded the tender to supply a maximum quantity of 100 kilograms of cannabis flower tops.